Implications of the Tumor Immune Microenvironment for Staging and Therapeutics - Robert A. Anders, MD, PhD | USCAP eLearning

Courses
Modern Pathology
Implications of the Tumor I...

Implications of the Tumor Immune Microenvironment for Staging and Therapeutics - Robert A. Anders, MD, PhD

Original release date: April 28, 2020
Access to this course expires on:  February 16, 2023 at 11:59 PM Pacific Time
CME 1

Faculty: Robert A. Anders, MD, PhD

Learning Objectives:

Understand the value of the tumor immune microenvironment in cancer patient prognosis
Discuss the use of microsatellite unstable (MSI HI) / mismatch repair deficiency testing in relation to immune based anti-cancer therapy.
Gain knowledge of how newer immune based anti-cancer therapies will likely impact diagnostic pathology
Explain the challenges in reporting PD-L1 immunohistochemical staining

$104.00 - $139.00

Items Included in the Purchase of this Section

Implications of the tumor immune microenvironment for staging and therapeutics

Presentation: Robert A. Anders, MD, PhD, 58 min 2 sec

CME Survey: Implications of the tumor immune microenvironment for staging and therapeutics

Survey: 1.0 CME 15 questions

Implications of the tumor immune microenvironment

Certificate: 0/2 Course items completed

SAM Test: Implications of the tumor immune microenvironment for staging and therapeutics

Assessment: 4 questions Unlimited retakes on fail

PowerPoint Presentation

Document: Implications of the tumor immune microenvironment for staging and therapeutics